-
Nature Medicine: How genes and small molecules affect our individual disease risk
Time of Update: 2023-01-05
Scientists at the University of Bosnia and Herzegovina have now identified rare and common changes in the genetic code that affect an individual's chemical fingerprint and personal disease profile.
-
Li Xiaoying and Zhang Yingmei "sugar heart" dialogue: Is diabetes still a critical disease such as coronary heart disease
Time of Update: 2022-12-04
↓↓↓ Click "Read Original" to learn more clinical skills*For medical professionals only"Heart" smells and looks weekly Heart WeeklyUnited Nations Diabetes Day is celebrated on 14 November every year, and this year's theme is "Education for Tomorrow".
-
Strength rating of Chinese pharmaceutical universities
Time of Update: 2022-11-26
01 Rating of pharmaceutical strength of Chinese universities01 Rating of pharmaceutical strength of Chinese universitiesThe 2022 Medical Strength Selection (see the end of the article for the results)
-
Neurology: Efficacy of endovascular thrombectomy in patients with acute stroke and cancer
Time of Update: 2022-11-26
A study published in Neurology used a large inpatient database, the National Inpatient Sample (NIS), to examine clinical outcomes in cancer patients undergoing EVT.
A study published in Neurology used a large inpatient database, the National Inpatient Sample (NIS), to examine clinical outcomes in cancer patients undergoing EVT.
-
3 new coronavirus infections in Dongcheng District The risk points involved were released and reported immediately if there was an intersection
Time of Update: 2022-11-01
3. Handling of the epidemicIn response to the epidemic situation in the district, Dongcheng District strictly and quickly investigated potential risks, implemented various prevention and control measures such as centralized isolation of risk personnel, home isolation, health monitoring, nucleic acid testing, etc.
-
The end of 2022 is approaching, and pharmaceutical executives are leaving
Time of Update: 2022-10-25
On October 10, Hengrui Pharmaceutical announced that the company's board of directors recently received a resignation report from Tao Weikang, deputy general manager of the company, and after resigning from the above position due to personal reasons, Tao Weikang will no longer hold any position in the company.
-
"Seeing" the internal structures of the body during physical rehabilitation
Time of Update: 2022-10-20
It has three components: motion tracking that captures motor activity, electrical impedance tomography (EIT), an imaging technology that measures muscle activity, and a virtual reality (VR) helmet and tracking suit that allows patients to watch themselves behave with the help of a physical therapist.
-
Experts from 6 hospitals including Peking Union Medical College Hospital jointly published the latest research results in the sub-journal of The Lancet
Time of Update: 2022-10-18
The results showed that among 106 patients with functional constipation aged 18 to 74 years, 64% of the vibrating capsule group increased the number of completely spontaneous bowel movements more than 1 time per week, which was 28% higher than that of the placebo control group .
-
Information on medical device licensing in each province (as of August 31, 2022
Time of Update: 2022-10-01
In order to further meet the needs of enterprises and the public to inquire about medical device regulatory information and strengthen social supervision and social co-governance, the State Food and
-
Sino-Korean Stroke Lipids Expert Forum
Time of Update: 2022-09-21
PCSK9i iloizumab significantly reduces LDL-C levels, stabilizes or reverses plaque, and significantly improves the clinical outcomes of stroke patients, and has a good safety profile, without increasing the risk of adverse events such as cognitive dysfunction and cerebral hemorrhage, so it has been recommended by many authoritative guidelines at home and abroad.
-
Give full play to the advantages of food and drug homologous products in Guangxi to promote industry revitalization and people's health - the establishment of a demonstration base in Guangxi (Nanning
Time of Update: 2022-08-31
In the post-pandemic era, health has become our common priority . With the improvement of people's material living standards, people not only pursue to eat well and eat well, but also pursue healthy
-
Guangdong Qide New Materials was listed, and invested 2 million to develop [degradable PP meltblown material] for the production of masks
Time of Update: 2022-08-28
Degradable PP meltblown material, invested 2 million in research and development, used for masks and protective clothingIn the prospectus, Qide New Materials introduced the company's research project - "Preparation Method of Degradable Polypropylene Meltblown Special Material".
-
The recovery of the global PMMA industry chain is long
Time of Update: 2022-08-23
In order to control the spread of the epidemic, China announced a comprehensive community lockdown in January this year, and other parts of Asia, including Europe and the United States, have since implemented lockdown measures in many countries around the world, leaving an already weak auto industry (production is expected to fall year-on-year).
-
In the first half of 2022, 12 medicines for children were approved
Time of Update: 2022-08-15
Table 2 New medicines for children approved in China in the first half of 2022 Source: Collation of public information Among the 12 new drugs approved in the first half of 2022, 7 are new dosage forms/specifications; they are mainly developed for children with poor compliance and differences in dosage from adults .
-
The innovation of biopharmaceutical companies accelerated, and more than 90 companies completed financing in the first quarter
Time of Update: 2022-08-10
Recently, many pharmaceutical companies have announced the completion of financing, which will be used for new drug research and development, promotion, At present, from the perspective of the industry as a whole, this wave of financing is still continuing.
